OST-HER2, together with palliative radiation therapy, increased median overall survival time in treated dogs from 159 days vs. 124 days in the RT-alone control group (p = 0.0237), according to the results of phase II clinical canine trial. The treatment was aimed at preventing amputation in frontline canine osteosarcoma.
In 2024, an estimated 6 million pet dogs will be diagnosed with cancer in the United States. As someone who has lost several family dogs to cancer, I know how heartbreaking this diagnosis will be for each of those dogs’ owners.
